Bibbò, S., Capone, E., Lovato, G., Lamolinara, A., Ponziani, S., Iezzi, M., Lattanzio, R., Mazzocco, K., Morini, M., Giansanti, F., De Laurenzi, V., Whitfield, J., Iacobelli, S., Ippoliti, R., Beaulieu, M-E., Soucek, L., Sala, A. and Sala, G. et al. (2024) 'EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate'. Journal of Controlled Release, 374. pp. 171 - 180. ISSN: 0168-3659

Cicirò, Y., Ragusa, D. and Sala, A. (2024) 'Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies'. Scientific Reports, 14 (1). pp. 1 - 15. ISSN: 2045-2322

Cicirò, Y., Ragusa, D., Tejera Nevado, P., Lattanzio, R., Sala, G., DesRochers, T., Millard, M., Andersson, MK., Stenman, G. and Sala, A. et al. (2023) 'The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma'. FEBS Letters, 598 (2). pp. 252 - 265. ISSN: 0014-5793

Tsakaneli, A., Carregari, VC., Morini, M., Eva, A., Cangemi, G., Chayka, O., Makarov, E., Bibbò, S., Capone, E., Sala, G., De Laurenzi, V., Poon, E., Chesler, L., Pieroni, L., Larsen, MR., Palmisano, G. and Sala, A. et al. (2022) 'MYC regulates metabolism through vesicular transfer of glycolytic kinases'. Open Biology, 11 (12). pp. 1 - 15. ISSN: 2046-2441

Tagalakis, AD., Jayarajan, V., Maeshima, R., Ho, KH., Syed, F., Wu, L-P., Aldossary, AM., Munye, MM., Mistry, T., Ogunbiyi, OK., Sala, A., Standing, JF., Moghimi, SM., Stoker, AW. and Hart, SL. et al. (2021) 'Integrin-Targeted, Short Interfering RNA Nanocomplexes for Neuroblastoma Tumor-Specific Delivery Achieve MYCN Silencing with Improved Survival'. Advanced Functional Materials, 31 (37). pp. 1 - 12. ISSN: 1616-301X

Cicirò, Y. and Sala, A. (2021) 'MYB oncoproteins: emerging players and potential therapeutic targets in human cancer'. Oncogenesis, 10 (2). pp. 1 - 15. ISSN: 2157-9024

Capone, E., Lamolinara, A., Pastorino, F., Gentile, R., Ponziani, S., Di Vittorio, G., D’Agostino, D., Bibbò, S., Rossi, C., Piccolo, E., Iacobelli, V., Lattanzio, R., Panella, V., Sallese, M., De Laurenzi, V., Giansanti, F., Sala, A., Iezzi, M., Ponzoni, M., Ippoliti, R., Iacobelli, S. and Sala, G. et al. (2020) 'Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma'. Cancers, 12 (10). pp. 1 - 18. ISSN: 2072-6694

Andersson, MK., Mangiapane, G., Nevado, PT., Tsakaneli, A., Carlsson, T., Corda, G., Nieddu, V., Abrahamian, C., Chayka, O., Rai, L., Wick, M., Kedaigle, A., Stenman, G. and Sala, A. et al. (2020) 'ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma'. Oncogenesis, 9 (1). pp. 5. ISSN: 2157-9024

Karteris, E., Nieddu, V., Piredda, R., Bexel, D., Barton, J., Anderson, J., Sebire, N., Kolluri, K., Janes, SM. and Sala, A. et al. (2019) 'Engineered human mesenchymal stem cells for neuroblastoma therapeutics'. Oncology Reports, 42 (1). pp. 1 - 8. ISSN: 1021-335X

Capone, E., Piccolo, E., Fichera, I., Ciufici, P., Barcaroli, D., Sala, A., De Laurenzi, V., Iacobelli, V., Iacobelli, S. and Sala, G. et al. (2017) 'Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma.'. Oncotarget, 8 (36). pp. 60368 - 60377. ISSN: 1949-2553

Sala, A. (2017) 'Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma'. Oncotarget, 8 (36). pp. 60368 - 60377. ISSN: 1949-2553

Sala, A. and corda, G. (2017) 'Non-canonical WNT/PCP signalling in cancer: Fzd6 takes centre stage.'. Oncogenesis, 6 (7). pp. e364. ISSN: 2157-9024

Corda, G., Sala, G., Lattanzio, R., Iezzi, M., Sallese, M., Fragassi, G., Lamolinara, A., Mirza, H., Barcaroli, D., Ermler, S., Silva, E., Yasaei, H., Newbold, RF., Vagnarelli, P., Mottolese, M., Natali, PG., Perracchio, L., Quist, J., Grigoriadis, A., Marra, P., Tutt, AN., Piantelli, M., Iacobelli, S., De Laurenzi, V. and Sala, A. et al. (2016) 'Functional and prognostic significance of the genomic amplification of frizzled receptor 6 ( FZD6 ) in breast cancer'. The Journal of Pathology, 241 (3). pp. 350 - 361. ISSN: 0022-3417

Corda, G. and Sala, A. (2016) 'Cutaneous cylindroma: it's all about MYB'. The Journal of Pathology, 29 (4). pp. 391 - 393. ISSN: 0022-3417

Dvorkina, M., Nieddu, V., Chakelam, S., Pezzolo, A., Cantilena, S., Leite, AP., Chayka, O., Regad, T., Pistorio, A., Sementa, AR., Virasami, A., Barton, J., Montano, X., Lechertier, T., Brindle, N., Morgenstern, D., LE Bras, M., Burns, A., Saunders, N., Hodivala-Dilke, K., Bagella, L., de The, H., Anderson, J., Sebire, N., Pistoia, V., Sala, A. and Salomoni, P. et al. (2016) 'A promyelocytic leukemia protein-thrombospondin 2 axis and the risk of relapse in neuroblastoma.'. Clinical cancer research : an official journal of the American Association for Cancer Research, 22 (13). pp. 3398 - 3409. ISSN: 1078-0432

Sala, A. (2015) 'Editorial: Targeting MYCN in pediatric cancers'. Frontiers in Oncology, 5 (MAY). pp. 1 - 2. ISSN: 2234-943X

Chayka, O., D'Acunto, CW., Middleton, O., Arab, M. and Sala, A. (2014) 'Identification and pharmacological inactivation of the MYCN gene network as a therapeutic strategy for neuroblastic tumor cells'. Journal of Biological Chemistry, 290 (4). pp. 2198 - 2212. ISSN: 0021-9258

Santilli, G., Anderson, J., Thrasher, AJ. and Sala, A. (2013) 'Catechins and antitumor immunity: Not MDSC's cup of tea'. OncoImmunology, 2 (6). pp. e24443 - e24443. ISSN: 2162-4011

Corvetta, D., Chayka, O., Gherardi, S., D'Acunto, CW., Cantilena, S., Valli, E., Piotrowska, I., Perini, G. and Sala, A. et al. (2013) 'Physical interaction between MYCN oncogene and polycomb repressive complex 2 (PRC2) in neuroblastoma: Functional and therapeutic implications'. Journal of Biological Chemistry, 288 (12). pp. 8332 - 8341. ISSN: 0021-9258

Santilli, G., Thrasher, AJ., Piotrowska, I., Cantilena, S., Chayka, O., D'Alicarnasso, M., Morgenstern, DA., Himoudi, N., Pearson, K., Anderson, J. and Sala, A. et al. (2013) 'Polyphenon E enhances the antitumor immune response in neuroblastoma by inactivating myeloid suppressor cells'. Clinical Cancer Research, 19 (5). pp. 1116 - 1125. ISSN: 1078-0432

Sala, A. (2012) 'c-MYB and TGF-β: EMT's dynamic duo in breast cancer'. Cell Cycle, 11 (1). pp. 17. ISSN: 1538-4101

Sottile, F., Gnemmi, I., Cantilena, S., D'Acunto, WC. and Sala, A. (2012) 'A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastoma'. Oncotarget, 3 (5). pp. 535 - 545. ISSN: 1949-2553

Cantilena, S., Pastorino, F., Pezzolo, A., Chayka, O., Pistoia, V., Ponzoni, M. and Sala, A. et al. (2011) 'Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas'. Oncotarget, 2 (12). pp. 976 - 983. ISSN: 1949-2553

Chaiwatanasirikul, K-A. and Sala, A. (2011) 'The tumour-suppressive function of CLU is explained by its localisation and interaction with HSP60'. Cell Death and Disease, 2 (10). ISSN: 2041-4889

Chaiwatanasirikul, KA. and Sala, A. (2011) 'The tumour-suppressive function of CLU is explained by its localisation and interaction with HSP60'. Cell Death and Disease. ISSN: 2041-4889

Gualdrini, F., Corvetta, D., Cantilena, S., Chayka, O., Tanno, B., Raschellà, G. and Sala, A. et al. (2010) 'Addiction of MYCN amplified tumours to B-MYB underscores a reciprocal regulatory loop'. Oncotarget, 1 (4). pp. 278 - 288. ISSN: 1949-2553

Bettuzzi, S., Davalli, P., Davoli, S., Chayka, O., Rizzi, F., Belloni, L., Pellacani, D., Fregni, G., Astancolle, S., Fassan, M., Corti, A., Baffa, R. and Sala, A. et al. (2009) 'Genetic inactivation of ApoJ/clusterin: Effects on prostate tumourigenesis and metastatic spread'. Oncogene, 28 (49). pp. 4344 - 4352. ISSN: 0950-9232

Sala, A., Bettuzzi, S., Pucci, S., Chayka, O., Dews, M. and Thomas-Tikhonenko, A. (2009) 'Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesis'. Advances in Cancer Research, 105 (1). pp. 115 - 132. ISSN: 0065-230X

Chayka, O., Corvetta, D., Dews, M., Caccamo, AE., Piotrowska, I., Santilli, G., Gibson, S., Sebire, NJ., Himoudi, N., Hogarty, MD., Anderson, J., Bettuzzi, S., Thomas-Tikhonenko, A. and Sala, A. et al. (2009) 'Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas'. Journal of the National Cancer Institute, 101 (9). pp. 663 - 677. ISSN: 0027-8874

Schwab, R., Bussolari, R., Corvetta, D., Chayka, O., Santilli, G., Kwok, JM., Ferrari-Amorotti, G., Tonini, GP., Iacoviello, L., Bertorelle, R., Menin, C., Hubank, M., Calabretta, B. and Sala, A. et al. (2008) 'Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk'. Oncogene, 27 (20). pp. 2929 - 2933. ISSN: 0950-9232

Schwab, R., Caccamo, A., Bettuzzi, S., Anderson, J. and Sala, A. (2007) 'B-MYB is hypophosphorylated and resistant to degradation in neuroblastoma: Implications for cell survival'. Blood Cells, Molecules, and Diseases, 39 (3). pp. 263 - 271. ISSN: 1079-9796

Santilli, G., Aronow, BJ. and Sala, A. (2003) 'Essential requirement of apolipoprotein J (clusterin) signaling for IkappaB expression and regulation of NF-kappaB activity'. Journal of Biological Chemistry, 278 (40). pp. 38214 - 38219. ISSN: 0021-9258